• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一只大白熊犬患I型Glanzmann血小板无力症。

Type I Glanzmann's thrombasthenia in a Great Pyrenees dog.

作者信息

Boudreaux M K, Kvam K, Dillon A R, Bourne C, Scott M, Schwartz K A, Toivio-Kinnucan M

机构信息

Department of Pathobiology, Auburn University, AL, USA.

出版信息

Vet Pathol. 1996 Sep;33(5):503-11. doi: 10.1177/030098589603300504.

DOI:10.1177/030098589603300504
PMID:8885176
Abstract

An 8-month-old female Great Pyrenees dog with chronic epistaxis and a history of gingival bleeding during shedding of deciduous teeth was evaluated for platelet function. Platelet morphology was normal at both the light and electron microscopic level. Platelet number and mean platelet volume were also normal. Platelet aggregation responses to adenosine diphosphate, collagen, platelet activating factor, and thrombin were markedly reduced, although shape change responses were normal. Clot retraction was markedly impaired. Monoclonal antibody (MoAb) Y2/51, a murine anti-human platelet beta 3 antibody that cross-reacts with canine platelet beta 3, and MoAb 5G11, a murine anti-dog platelet alpha IIb beta 3 antibody, bound minimally to affected dog platelets, as demonstrated by flow cytometry. Binding of MoAb Y2/51 was not detectable by immunoblot. MoAb CAP1, a murine anti-dog fibrinogen receptor-induced binding site antibody, failed to bind to affected dog platelets, as demonstrated by flow cytometry. A reduction in glycoproteins alpha IIb and beta 3 was demonstrated by two-dimensional protein electrophoresis. This is the first reported case of type I Glanzmann's thrombasthenia in the dog that closely resembles the clinical syndrome and the platelet morphology described in type I Glanzmann's thrombasthenia of human beings.

摘要

对一只8个月大的雌性大白熊犬进行了血小板功能评估,该犬患有慢性鼻出血,且在乳牙脱落时有牙龈出血史。光镜和电镜下血小板形态均正常。血小板数量和平均血小板体积也正常。尽管形状改变反应正常,但血小板对二磷酸腺苷、胶原、血小板活化因子和凝血酶的聚集反应明显降低。血块回缩明显受损。流式细胞术显示,鼠抗人血小板β3抗体(与犬血小板β3发生交叉反应)单克隆抗体(MoAb)Y2/51和鼠抗犬血小板αIIbβ3抗体MoAb 5G11与患病犬血小板的结合极少。免疫印迹法未检测到MoAb Y2/51的结合。流式细胞术显示,鼠抗犬纤维蛋白原受体诱导结合位点抗体MoAb CAP1未能与患病犬血小板结合。二维蛋白质电泳显示糖蛋白αIIb和β3减少。这是首次报道的犬I型Glanzmann血小板无力症病例,与人类I型Glanzmann血小板无力症所描述的临床综合征和血小板形态极为相似。

相似文献

1
Type I Glanzmann's thrombasthenia in a Great Pyrenees dog.一只大白熊犬患I型Glanzmann血小板无力症。
Vet Pathol. 1996 Sep;33(5):503-11. doi: 10.1177/030098589603300504.
2
A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.一种新的Glanzmann血小板无力症变异型(斯特拉斯堡I型)。血小板糖蛋白IIb-IIIa复合物功能缺陷,存在糖蛋白IIIa 214Arg→214Trp突变。
J Clin Invest. 1992 Jun;89(6):1995-2004. doi: 10.1172/JCI115808.
3
Clinical, biochemical, and molecular aspects of Glanzmann's thrombasthenia in humans and dogs.人类和犬类中Glanzmann血小板无力症的临床、生化及分子方面
Vet Pathol. 2001 May;38(3):249-60. doi: 10.1354/vp.38-3-249.
4
A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.一名中国Glanzmann血小板无力症患者血小板糖蛋白IIIa(β3)的Cys374Tyr纯合突变。
Blood. 1996 Sep 1;88(5):1666-75.
5
Two genetic defects in alphaIIb are associated with type I Glanzmann's thrombasthenia in a Great Pyrenees dog: a 14-base insertion in exon 13 and a splicing defect of intron 13.在一只大白熊犬中,αIIb基因的两种遗传缺陷与I型Glanzmann血小板无力症相关:外显子13中的14个碱基插入和内含子13的剪接缺陷。
Vet Pathol. 2000 Nov;37(6):581-8. doi: 10.1354/vp.37-6-581.
6
A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.一种以糖蛋白IIb/IIIa复合物形成异常为特征的Glanzmann血小板无力症变体。
Thromb Haemost. 1989 Nov 24;62(3):977-83.
7
Glanzmann's thrombasthenia: updated.血小板无力症:最新进展。
Platelets. 2002 Nov;13(7):387-93. doi: 10.1080/0953710021000024394.
8
Protein and glycoprotein abnormalities in an unusual subtype of Glanzmann's thrombasthenia.血小板无力症一种不寻常亚型中的蛋白质和糖蛋白异常
Haemostasis. 1982;12(4):337-44. doi: 10.1159/000214691.
9
Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.伊朗使用流式细胞仪法对 Glanzmann 血小板无力症患者进行分类。
Platelets. 2011;22(5):321-7. doi: 10.3109/09537104.2011.556275. Epub 2011 Apr 28.
10
Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.在Glanzmann血小板无力症的一个变体中,残余血小板糖蛋白IIb/IIIa复合物的稳定性降低和结构异质性
Br J Haematol. 1989 Dec;73(4):514-21. doi: 10.1111/j.1365-2141.1989.tb00290.x.

引用本文的文献

1
Precision medicine identifies a pathogenic variant of the ITGA2B gene responsible for Glanzmann's thrombasthenia in a cat.精准医学鉴定出一只猫的 Glanzmann 血小板无力症的 ITGA2B 基因突变。
J Vet Intern Med. 2020 Nov;34(6):2438-2446. doi: 10.1111/jvim.15886. Epub 2020 Sep 16.
2
Platelet Function and Therapeutic Applications in Dogs: Current Status and Future Prospects.犬类血小板功能及其治疗应用:现状与未来展望
Animals (Basel). 2020 Jan 25;10(2):201. doi: 10.3390/ani10020201.
3
Identification and Characterization of Glanzmann Thrombasthenia in 2 Closely Related Mixed-breed Dogs.
2只亲缘关系密切的混种犬中Glanzmann血小板无力症的鉴定与特征分析
J Vet Intern Med. 2016 Mar-Apr;30(2):642-6. doi: 10.1111/jvim.13825. Epub 2016 Jan 14.
4
Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.用于人类免疫和血细胞系统遗传疾病基因治疗的潜在大型动物模型。
ILAR J. 2009;50(2):168-86. doi: 10.1093/ilar.50.2.168.